欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Arabidopsis thaliana Phosphoinositide phospholipase C 9 (PLC9), partial CSB-YP750716DOA
CSB-EP750716DOA
CSB-BP750716DOA
CSB-MP750716DOA
CSB-EP750716DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable glucuronoxylan glucuronosyltransferase F8H (F8H), partial CSB-YP750717DOA
CSB-EP750717DOA
CSB-BP750717DOA
CSB-MP750717DOA
CSB-EP750717DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster MOXD1 homolog 2 (olf413), partial CSB-YP750718DLU1
CSB-EP750718DLU1
CSB-BP750718DLU1
CSB-MP750718DLU1
CSB-EP750718DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Thioredoxin Y1, chloroplastic (At1g76760) CSB-YP750719DOA
CSB-EP750719DOA
CSB-BP750719DOA
CSB-MP750719DOA
CSB-EP750719DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana NADPH-dependent diflavin oxidoreductase ATR3 (ATR3), partial CSB-YP750720DOA
CSB-EP750720DOA
CSB-BP750720DOA
CSB-MP750720DOA
CSB-EP750720DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Beta-1,3-galactosyltransferase 7 (B3GALT7), partial CSB-YP750721DOA
CSB-EP750721DOA
CSB-BP750721DOA
CSB-MP750721DOA
CSB-EP750721DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Uncharacterized protein KIAA0090 homolog, partial CSB-YP750722XBE
CSB-EP750722XBE
CSB-BP750722XBE
CSB-MP750722XBE
CSB-EP750722XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Exonuclease 3'-5' domain-containing protein 1 (exd1) CSB-YP750723XBE
CSB-EP750723XBE
CSB-BP750723XBE
CSB-MP750723XBE
CSB-EP750723XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis SOSS complex subunit B1-B (obfc2b-b) CSB-YP750724XBE
CSB-EP750724XBE
CSB-BP750724XBE
CSB-MP750724XBE
CSB-EP750724XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Kelch-like protein 12 (klhl12), partial CSB-YP750725XBE
CSB-EP750725XBE
CSB-BP750725XBE
CSB-MP750725XBE
CSB-EP750725XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Ankyrin repeat domain-containing protein SOWAHB (sowahb), partial CSB-YP750726XBE
CSB-EP750726XBE
CSB-BP750726XBE
CSB-MP750726XBE
CSB-EP750726XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Zinc transporter ZIP9-B (slc39a9-b), partial CSB-YP750727XBE
CSB-EP750727XBE
CSB-BP750727XBE
CSB-MP750727XBE
CSB-EP750727XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis PQ-loop repeat-containing protein 1 (pqlc1), partial CSB-YP750728XBE1
CSB-EP750728XBE1
CSB-BP750728XBE1
CSB-MP750728XBE1
CSB-EP750728XBE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Mdm2-binding protein (mtbp), partial CSB-YP750729XBE
CSB-EP750729XBE
CSB-BP750729XBE
CSB-MP750729XBE
CSB-EP750729XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Collagen type IV alpha-3-binding protein (col4a3bp), partial CSB-YP750730XBE
CSB-EP750730XBE
CSB-BP750730XBE
CSB-MP750730XBE
CSB-EP750730XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Protein RRP5 homolog (Pdcd11), partial CSB-YP750731MO
CSB-EP750731MO
CSB-BP750731MO
CSB-MP750731MO
CSB-EP750731MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse APC membrane recruitment protein 3 (Fam123c) CSB-YP750732MO
CSB-EP750732MO
CSB-BP750732MO
CSB-MP750732MO
CSB-EP750732MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Uncharacterized protein KIAA1841 (KIAA1841) CSB-YP750733HU
CSB-EP750733HU
CSB-BP750733HU
CSB-MP750733HU
CSB-EP750733HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Protein FAM149B1 (Fam149b1) CSB-YP750734MO
CSB-EP750734MO
CSB-BP750734MO
CSB-MP750734MO
CSB-EP750734MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Coiled-coil domain-containing protein 70 (CCDC70) CSB-YP750735HU
CSB-EP750735HU
CSB-BP750735HU
CSB-MP750735HU
CSB-EP750735HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×